Ghana: FDA unveils new online advertisement application portal

The Food and Drugs Authority (FDA) has unveiled a new Online Advertisement Application Portal, marking a significant milestone in the organization’s ongoing efforts toward digital transformation.

The launch event, hosted at the T.C. Corquaye Conference Room within the FDA offices, gathered members of the FDA’s Executive Committee, along with management, directors, partners, and key stakeholders.

This innovative portal is designed to simplify the submission, review, and approval process for advertisements of FDA-regulated products, representing a substantial enhancement in service delivery.

During the launch, Dr. Delese Darko, Chief Executive Officer of the FDA, highlighted that the platform is intended to boost convenience, transparency, and accessibility, enabling customers to submit advertisements, process payments, and receive approvals entirely online, eliminating the need for physical visits.

“This is a momentous occasion for us,” the FDA representative said in the welcome address. “The launch of this platform reflects our commitment to innovation, efficiency, and customer-centricity. It’s a leap forward in how we interact, engage, and serve our stakeholders.”

The FDA’s mandate under the Public Health Act, 2012 (Act 851), includes the regulation of product advertisements. The new portal is expected to significantly simplify this process, providing a clear and traceable record of all transactions and communications. This move is aimed at ensuring transparency and accountability in the advertising process for all stakeholders.

The development of the portal was made possible through collaboration with Proper-Alliance, an affiliate of the AFCTA Network Hub, alongside other key partners. The FDA expressed its deep appreciation to everyone who contributed to bringing this project to fruition.

As the FDA continues to evolve with the changing demands of the industry, the organization reaffirmed its dedication to ongoing enhancements. The new portal is one of several initiatives designed to foster a safe, transparent, and efficient regulatory environment in Ghana.

The FDA urges all stakeholders to adopt the new platform and join in the collective effort to uphold the highest standards of product quality and safety nationwide.